Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the effect of a new von Willebrand factor concentrate on bleeding
time, in vivo recovery, and circulating half-life of the infused factor in patients with von
Willebrand's disease.
II. Assess the safety of von Willebrand factor in these patients.